Gonzalez Richard A's Form 4 filing
AbbVie Inc. (ABBV) · filed Jul 19, 2024
- Accession no.
- 0000897069-24-001526
- Filed
- Jul 19, 2024
- Trade date
- Jul 17, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market sales total $49.5M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gonzalez Richard ACIK 0001239127 | Director, Officer (EXECUTIVE CHAIRMAN OF BOARD) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 17, 2024 | Common Stock, $0.01 par value | MOption exerciseAcquired | +87,050 | $61.36 | +$5,341,388 | 600,149 | Direct | |
| Jul 17, 2024 | Common Stock, $0.01 par value | MOption exerciseAcquired | +119,418 | $79.02 | +$9,436,410.36 | 719,567 | Direct | |
| Jul 17, 2024 | Common Stock, $0.01 par value | MOption exerciseAcquired | +76,377 | $93.50 | +$7,141,249.5 | 795,944 | Direct | |
| Jul 17, 2024 | Common Stock, $0.01 par value | SSaleDisposed | −282,845 | $175.00 | −$49,497,875 | 513,099 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 17, 2024 | Common Stock | MOption exerciseDisposed | −87,050 | $0.00 | $0 | 0 | Direct | |
| Jul 17, 2024 | Common Stock | MOption exerciseDisposed | −119,418 | $0.00 | $0 | 59,709 | Direct | |
| Jul 17, 2024 | Common Stock | MOption exerciseDisposed | −76,377 | $0.00 | $0 | 152,755 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
The option exercise and sale transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).